Stifel Financial’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTLA
Stifel Financial's NTLA Position: Q3 2026 in Review
Stifel Financial increased its Intellia Therapeutics (NTLA) stake by 0.39% in Q3 2026, buying an estimated $49.4K and bringing the position to 1,018,340 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #890.
Stifel Financial first reported a position in NTLA in Q3 2018 and has held it in 25 quarters since. The position peaked at $17.2M in Q2 2026. 308 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.
- Stifel Financial held 1,018,340 shares of Intellia Therapeutics worth $12.3M as of Q3 2026.
- Stifel Financial bought 3,953 Intellia Therapeutics shares in Q3 2026, an estimated $49.4K.
- Intellia Therapeutics made up 0.01% of Stifel Financial's portfolio in Q3 2026, its #890 holding.
- Stifel Financial first reported a position in Intellia Therapeutics in Q3 2018 and has held it in 25 quarters since.
- Stifel Financial's Intellia Therapeutics position peaked at $17.2M in Q2 2026.
- 308 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.
Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.